Skip to main content
Figure 1 | Cancer Cell International

Figure 1

From: MiR-99a may serve as a potential oncogene in pediatric myeloid leukemia

Figure 1

The expression of miR-99a assessed by real-time qRT-PCR in pediatric AML (M1-M5) (A) and CML (B) patients before and after therapy. The data were normalized against U6 expression in the same patient. *Pā€‰<ā€‰0.05, **Pā€‰<ā€‰0.01. There was only one patient with AML-M1 available for evaluation and thus no statistical analysis was performed.

Back to article page